NIHR i4i Challenge Awards
3 - 5 years
No upper funding limit
12.01.2022
NIHR i4i Challenge Awards competition 13, supports market-ready innovations by addressing the translational gap between the clinical evaluation of technologies and their adoption. Welcome innovations include medical devices, digital products, and in-vitro diagnostics.
Check Your Eligibility
The i4i Programme will fund the generation of clinical evidence required for the implementation of technological innovations in the healthcare pathway, based on their use in a real-world context. In other words, the testing would be carried out as if the innovation was being used in service. This might include feasibility or effectiveness studies carried out in real-world settings that employ pragmatic study designs such as pathway and sustainability evaluations, qualitative assessments of the clinical burden, and assessments of broader downstream effects. Companies and NHS organisations may receive up to 100% of the requested funding, with no requirement for matched funding for commercial organisations.
The objectives of the i4i Challenge Awards are to:
Requirements include the following:
The i4i challenge award will not fund: